Form 4: Zevra Therapeutics Chief Legal Officer Receives 200,000 Restricted Stock Units

Rahsaan Thompson, Chief Legal & Compliance Secretary of Zevra Therapeutics, was granted 200,000 restricted stock units on June 21, 2024, under the company's 2023 Employment Inducement Award Plan.

Summary

• Rahsaan Thompson, the Chief Legal & Compliance Secretary of Zevra Therapeutics, received a grant of 200,000 restricted stock units (RSUs) on June 21, 2024.
• The RSUs were granted under the Issuer's 2023 Employment Inducement Award Plan.
• 33 1/3% of the shares will vest on June 21, 2025, with the remaining shares vesting in two equal annual installments thereafter, contingent upon continued employment.
• Full vesting occurs upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a standard executive compensation practice. The grant itself is neither overwhelmingly positive nor negative.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule incentivizes continued employment and commitment to the company's success.

Risks

• The value of the RSUs is dependent on the future performance of Zevra Therapeutics' stock.
• The vesting schedule is contingent upon continued employment, which introduces a risk of forfeiture.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the pharmaceutical industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages, including RSU grants, are common in the pharmaceutical industry to attract and retain talent.
• The vesting schedule is fairly standard, with vesting tied to continued employment and accelerated vesting upon a change of control.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the executive to drive company performance.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates